Abstract
Silicene, a two-dimensional allotrope of silicon, has attracted considerable attention due to its distinctive electronic, mechanical, and biochemical properties. This review critically examines the emerging applications of silicene in oncology, emphasising its potential roles in cancer therapy and research. Silicene exhibits exceptional biocompatibility and surface reactivity, positioning it as a promising candidate for oncological applications. This review addresses the current challenges and limitations in the clinical translation of silicene-based technologies, including issues of stability, toxicity, and scalable production. By synthesizing recent research findings, this review aims to provide an assessment of silicene's potential contributions to oncology and delineate future research trajectories in this innovative field.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
